RobertStolerMDFACC, FSCAI

Interventional Cardiology

Director Interventional Cardiology, Co-Chief Division of Cardiology, Baylor Heart & Vascular Hospital at Baylor University Medical Center. Clinical Professor of Medicine, Texas A&M College of Medicine

Join to view full profile

Dr. Stoler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Stoler's full profile

Already have an account?

Office
621 N Hall St
Suite 500
Dallas, TX 75226
Phone+1 469-800-7400

Summary

Dr. Robert Stoler is a cardiologist in Dallas, TX and is affiliated with Baylor Jack and Jane Hamilton Heart and Vascular Hospital and Baylor University Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 27 years. He specializes in interventional cardiology and is experienced in general cardiology, valvular heart disease, cardiac catheterization, and percutaneous coronary intervention. He continues to be extensively involved in research developing and testing devices used to treat coronary and valvular heart disease.

Education & Training

Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1993 - 1997
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1990 - 1993
Duke University School of MedicineClass of 1990
Duke UniversityBA, Economics, Suma Cum Laude, 1982 - 1986

Certifications & Licensure

TX State Medical License 1991 - 2025
MA State Medical License 1993 - 2024
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Hall of Fame D Magazine
Dallas' Best Doctors D Magazine
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
Completed
Not Applicable
BIOFLOW-III All-comers Orsiro Safety and Performance Registry Start of enrollment: 2011 Aug 01
Unknown status
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Active, not recruiting
COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT Start of enrollment: 2013 Aug 21
Completed
Not Applicable
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent Start of enrollment: 2013 Sep 01
Unknown status
Not Applicable
DEFLECT III: A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During TAVI Start of enrollment: 2014 Feb 01
Completed
Not Applicable
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2014 Sep 22
Terminated
Not Applicable
Medtronic CoreValve Evolut R U.S. Clinical Study Start of enrollment: 2014 Aug 01
Completed
Not Applicable
Expanded Clinical Study of the Tendyne Mitral Valve System Start of enrollment: 2014 Nov 01
Active, not recruiting
Not Applicable
Medtronic Resolute Onyx 2.0 mm Clinical Study Start of enrollment: 2015 Apr 06
Completed
Not Applicable
The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation Start of enrollment: 2016 Jun 01
Completed
Not Applicable
EVOLVE Short DAPT Study Start of enrollment: 2016 Feb 16
Completed
Phase 4
EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis Start of enrollment: 2017 Jul 12
Active, not recruiting
Not Applicable
RESOLUTE ONYX Post-Approval Study Start of enrollment: 2017 Mar 30
Completed
Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis Start of enrollment: 2015 May 01
Recruiting
A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients Start of enrollment: 2017 Nov 02
Completed
Not Applicable
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) Start of enrollment: 2018 Apr 12
Completed
Phase 3
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation Start of enrollment: 2018 Jun 15
Recruiting
Not Applicable
Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcification Start of enrollment: 2018 Oct 10
Active, not recruiting
Not Applicable
Disrupt CAD III With the Shockwave Coronary IVL System Start of enrollment: 2019 Jan 09
Completed
Not Applicable
ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10
Recruiting
Not Applicable
A Clinical Trial to Confirm Safety & Effectiveness of the SYNERGY 4.50 mm and 5.00 mm Stent for Treatment of Atherosclerotic Lesion(s) Start of enrollment: 2019 May 09
Completed
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement Start of enrollment: 2020 Feb 07
Completed
Not Applicable
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions Start of enrollment: 2020 Jan 24
Active, not recruiting
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) Start of enrollment: 2021 May 11
Active, not recruiting
Phase 3
A U.S Post Approval Study Evaluating the SYNERGY XLV (MEGATRON) Stent System Start of enrollment: 2021 Apr 14
Completed
Join now to see all

Publications & Presentations

PubMed

A Giant Left Anterior Descending Artery Aneurysm and an Updated Review on Coronary Aneurysms.
Aldo E Rafael-Yarihuaman, Jerry Wang, Cristhian Guevara, Avantika Banerjee, Robert C Stoler
The American Journal of Cardiology. 2024-11-15
Five-Year Outcomes of Measured and Predicted Prosthesis-Patient Mismatch following Transcatheter Aortic Valve Implantation.
Karim Al-Azizi, Ghadi Moubarak, Asim Mohiuddin, Molly Szerlip, Srinivasa Potluri
The American Journal of Cardiology. 2024-11-15
Cerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial.
Raj R Makkar, Aakriti Gupta, Thomas E Waggoner, Samuel Horr, Juhana Karha
JAMA Cardiology. 2024-10-29

Journal Articles

Necropsy Findings Early After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
18. Roberts WC, Stoler RC, Grayburn PA, Hebeler RF, Ko JM, Brown DL, Brinkman WT, Mack MJ, Guileyardo JM, American Journal of Cardiology, 11/29/2012
Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention
17. Munter P, Mann DM, Woodward M, Choi JW, Stoler RC, Daichi S, Farkouh ME, Kim MC., American Journal of Cardiology 108: 822-27, 2011
AmBulatory Closure Device Percutaneous Intervention (ABCD-PCI) Study: A Single Center Experience.
16. Falcone AM, Bose R, Stoler RC, Kim M, Laible E, Kang L, Waters K, Dunkerley J, Choi JW., Proc (Bayl Univ Med Cent) 24(3), 2011
Anomalous Origin of the Right Coronary Artery from the Left Sinus of Valsalva Associated with Syncope in a Young Athlete
Lilly SM, Schussler JM, Stoler RC, Proc (Bayl Univ Med Cent) 24(1), 2011
A Randomized Comparison of a Novel Bioabsorbable Vascular Closure Device Versus Manual Compression in the Achievement of Hemostasis After Percutaneous Femoral Procedures.
14. Wong SC, Bachinsky W, Cambier P, Stoler R, Janah A, Rogers J, Hermiller J, Nair R, Hutman H, Wang H, et al, Journal of the American College of Cardiology 2:785-793, 2009
Percutaneous coronary artery stenting of unprotected left main coronary artery disease using drug eluting stents: the initial Baylor University Medical Center experie...
11. Garner WL, Stoler RC, Laible EA, Kang, MJ, Choi JW, Proceedings (Baylor University Medical Center) 20(4): 339-343, 2007
Use of multislice computed tomographic coronary angiography for the diagnosis of anomalous coronary arteries.
7. Berbarie RF, Dockery WD, Johnson KB, Rosenthal RL, Stoler RC, Schussler JM., American Journal of Cardiology 98(3):402-6., 8/1/2006
Safety and Efficacy of Staple-Mediated Femoral Arteriotomy Closure: Results from a Randomized Multicenter Study.
13. Ansel G, Yakubov S, Neilsen C, Allie D, Stoler R, Hall P, Fail P, Sanborn T, Caputo R, Catheterization and Cardiovascular Interventions 67:546–553, 2006
Computed tomographic coronary angiography: experience at Baylor University Medical Center/Baylor Jack and Jane Hamilton Heart and Vascular Hospital
9. Schussler JM, Dockery WD, Moore TR, Johnson KB, Rosenthal RL, Stoler RC., Proceedings (Baylor University Medical Center) 18(3):228-33., 7/2005
Postpartum Multivessel Spontaneous Coronary Artery Dissection Confirmed by Coronary CT Angiography
12. Schroder C, Stoler RC, Branning GB, Choi JW, Proceedings (Baylor University Medical Center)19:338-41, 2005
Images in cardiovascular medicine. Superiority of computed tomography coronary angiography over calcium scoring to accurately evaluate atherosclerotic disease in a 35...
10. Schussler JM, Dockery WD, Johnson KB, Rosenthal RL, Schumacher JR, Stoler RC, Circulation ; 109 (23): e318-19, 6/15/2004
Chest Pain
6. Pluenneke A, Stoler RC, Roberts WC., Proceedings (Baylor University Medical Center ) 12: 305-308., 1999
Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
5. Caputo RP, Ho KKL, Stoler RC, Sukin CA, Lopez JJ, Cohen DJ, Kuntz RE, Berman A, Carrozza JP, Baim DS., American Journal of Cardiology 79(9):1159-64,, 5/1997
Percutaneous treatment of left main coronary stenosis with new devices: acute angiographic results and intermediate follow-up.
4. Lopez JJ, Ho KKL, Stoler RC, Caputo RP, Carrozza JP, Kuntz RE, Baim DS, Cohen DJ., Journal of the American College of Cardiology 29(2):345-52, 2/1997
Stent jail: a minimum security prison.
3. Caputo RP, Chafizadeh ER, Stoler RC, Lopez JJ, Cohen DJ, Kuntz RE, Carrozza JP, Baim DS, American Journal of Cardiology 77:1226-1230., 1996
Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs
2. Tanaka M, Brooks SE, Richard VJ, FitzHarris GP, Stoler RC, Jennings RB, Arfors KE, Reimer KA., Circulation 87:526-535., 1993
Evidence against the "early protection-delayed death" hypothesis of superoxide dismutase therapy in experimental myocardial infarction: polyethylene glycol-superoxide ...
1. Tanaka M, Stoler RC, FitzHarris GP, Jennings RB, Reimer KA, Circulation Research 67:636-644., 1990
Join now to see all

Press Mentions

‘Game Changer' Hypertension Procedure Could Help People with Resistant High Blood PressureDecember 18th, 2023
BSW-DALLAS Adds New FDA-Approved Option for Resistant High Blood PressureJanuary 30th, 2024
Dallas Hospital Reveals Hypertension ProtocolFebruary 4th, 2024